{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:14:36Z","timestamp":1794640476199,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073832"],"award-info":[{"award-number":["82073832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204885"],"award-info":[{"award-number":["82204885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973792"],"award-info":[{"award-number":["81973792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tuberous sclerosis complex is a genetic disorder caused by mutations in the <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> genes, affecting multiple systems. These genes produce proteins that regulate mTORC1 activity, essential for cell function and metabolism. While mTOR inhibitors have advanced treatment, maintaining long-term therapeutic success is still challenging. For over 20 years, significant progress has linked <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> gene mutations in stem cells to tuberous sclerosis complex symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A comprehensive review was conducted using databases like Web of Science, Google Scholar, PubMed, and Science Direct, with search terms such as \u201ctuberous sclerosis complex,\u201d \u201cTSC1,\u201d \u201cTSC2,\u201d \u201cstem cell,\u201d \u201cproliferation,\u201d and \u201cdifferentiation.\u201d Relevant literature was thoroughly analyzed and summarized to present an updated analysis of the TSC1-TSC2 complex\u2019s role in stem cell fate determination and its implications for tuberous sclerosis complex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The TSC1-TSC2 complex plays a crucial role in various stem cells, such as neural, germline, nephron progenitor, intestinal, hematopoietic, and mesenchymal stem\/stromal cells, primarily through the mTOR signaling pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This review aims shed light on the role of the TSC1-TSC2 complex in stem cell fate, its impact on health and disease, and potential new treatments for tuberous sclerosis complex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13287-025-04170-3","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T03:11:23Z","timestamp":1738638683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate"],"prefix":"10.1186","volume":"16","author":[{"given":"Shuang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Nong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Gui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8198-9911","authenticated-orcid":false,"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"4170_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"P Crino","year":"2006","unstructured":"Crino P, Nathanson K, Henske E. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345\u201356. https:\/\/doi.org\/10.1056\/NEJMra055323","journal-title":"N Engl J Med"},{"key":"4170_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger D. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243\u201354. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.001","journal-title":"Pediatr Neurol"},{"key":"4170_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/s1474-4422(22)00213-7","volume":"21","author":"P Curatolo","year":"2022","unstructured":"Curatolo P, Specchio N, Aronica E. Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy. Lancet Neurol. 2022;21:843\u201356. https:\/\/doi.org\/10.1016\/s1474-4422(22)00213-7","journal-title":"Lancet Neurol"},{"key":"4170_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet (London England). 2008;372:657\u201368. https:\/\/doi.org\/10.1016\/s0140-6736(08)61279-9","journal-title":"Lancet (London England)"},{"key":"4170_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68:64\u201380. https:\/\/doi.org\/10.1086\/316951","journal-title":"Am J Hum Genet"},{"key":"4170_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-z","volume":"75","author":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","year":"1993","unstructured":"Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305\u201315. https:\/\/doi.org\/10.1016\/0092-8674(93)90618-z","journal-title":"Cell"},{"key":"4170_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","volume":"13","author":"EP Henske","year":"1995","unstructured":"Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 1995;13:295\u20138. https:\/\/doi.org\/10.1002\/gcc.2870130411","journal-title":"Genes Chromosomes Cancer"},{"key":"4170_CR8","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"E Henske","year":"2016","unstructured":"Henske E, J\u00f3\u017awiak S, Kingswood J, Sampson J, Thiele E. Tuberous sclerosis complex. Nature reviews. Disease Primers. 2016;2:16035. https:\/\/doi.org\/10.1038\/nrdp.2016.35","journal-title":"Disease Primers"},{"key":"4170_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1494","volume":"37","author":"K Inoki","year":"2005","unstructured":"Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 2005;37:19\u201324. https:\/\/doi.org\/10.1038\/ng1494","journal-title":"Nat Genet"},{"key":"4170_CR10","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and\u2013\u20092 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA. 2002;99:13571\u20136. https:\/\/doi.org\/10.1073\/pnas.202476899","journal-title":"Proc Natl Acad Sci USA"},{"key":"4170_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ncb847","volume":"4","author":"X Gao","year":"2002","unstructured":"Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung R, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol. 2002;4:699\u2013704. https:\/\/doi.org\/10.1038\/ncb847","journal-title":"Nat Cell Biol"},{"key":"4170_CR12","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/wnl.0000000000007749","volume":"93","author":"IE Overwater","year":"2019","unstructured":"Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, et al. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. 2019;93:e200\u20139. https:\/\/doi.org\/10.1212\/wnl.0000000000007749","journal-title":"Neurology"},{"key":"4170_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10:68. https:\/\/doi.org\/10.1186\/s13287-019-1165-5","journal-title":"Stem Cell Res Ther"},{"key":"4170_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based Cell Therapy-Promise and challenges. Cell Stem Cell. 2020;27:523\u201331. https:\/\/doi.org\/10.1016\/j.stem.2020.09.014","journal-title":"Cell Stem Cell"},{"key":"4170_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell. 2012;47:535\u201346. https:\/\/doi.org\/10.1016\/j.molcel.2012.06.009","journal-title":"Mol Cell"},{"key":"4170_CR16","doi-asserted-by":"publisher","first-page":"35647","DOI":"10.1074\/jbc.274.50.35647","volume":"274","author":"M Nellist","year":"1999","unstructured":"Nellist M, van Slegtenhorst M, Goedbloed M, van den Ouweland A, Halley D, van der Sluijs P. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem. 1999;274:35647\u201352. https:\/\/doi.org\/10.1074\/jbc.274.50.35647","journal-title":"J Biol Chem"},{"key":"4170_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41467-020-20522-4","volume":"12","author":"H Yang","year":"2021","unstructured":"Yang H, Yu Z, Chen X, Li J, Li N, Cheng J, et al. Structural insights into TSC complex assembly and GAP activity on Rheb. Nat Commun. 2021;12:339. https:\/\/doi.org\/10.1038\/s41467-020-20522-4","journal-title":"Nat Commun"},{"key":"4170_CR18","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1093\/hmg\/10.25.2889","volume":"10","author":"M Nellist","year":"2001","unstructured":"Nellist M, Verhaaf B, Goedbloed M, Reuser A, van den Ouweland A, Halley D. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Hum Mol Genet. 2001;10:2889\u201398. https:\/\/doi.org\/10.1093\/hmg\/10.25.2889","journal-title":"Hum Mol Genet"},{"key":"4170_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.21542","volume":"118","author":"J Jozwiak","year":"2006","unstructured":"Jozwiak J. Hamartin and tuberin: working together for tumour suppression. Int J Cancer. 2006;118:1\u20135. https:\/\/doi.org\/10.1002\/ijc.21542","journal-title":"Int J Cancer"},{"key":"4170_CR20","doi-asserted-by":"publisher","first-page":"582368","DOI":"10.3389\/fgene.2020.582368","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, Ren C, Stone C, Chandra A, Xu J, Li N, et al. Hamartin: an endogenous neuroprotective Molecule Induced by Hypoxic Preconditioning. Front Genet. 2020;11:582368. https:\/\/doi.org\/10.3389\/fgene.2020.582368","journal-title":"Front Genet"},{"key":"4170_CR21","doi-asserted-by":"publisher","first-page":"44180","DOI":"10.1074\/jbc.M207211200","volume":"277","author":"L Haddad","year":"2002","unstructured":"Haddad L, Smith N, Bowser M, Niida Y, Murthy V, Gonzalez-Agosti C, et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. J Biol Chem. 2002;277:44180\u20136. https:\/\/doi.org\/10.1074\/jbc.M207211200","journal-title":"J Biol Chem"},{"key":"4170_CR22","doi-asserted-by":"publisher","first-page":"16409","DOI":"10.1074\/jbc.270.27.16409","volume":"270","author":"R Wienecke","year":"1995","unstructured":"Wienecke R, K\u00f6nig A, DeClue J. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem. 1995;270:16409\u201314. https:\/\/doi.org\/10.1074\/jbc.270.27.16409","journal-title":"J Biol Chem"},{"key":"4170_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jmedgenet-2013-101680","volume":"50","author":"JM Capo-Chichi","year":"2013","unstructured":"Capo-Chichi JM, Tcherkezian J, Hamdan FF, D\u00e9carie JC, Dobrzeniecka S, Patry L, et al. Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet. 2013;50:740\u20134. https:\/\/doi.org\/10.1136\/jmedgenet-2013-101680","journal-title":"J Med Genet"},{"key":"4170_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/humu.22529","volume":"35","author":"AA Alfaiz","year":"2014","unstructured":"Alfaiz AA, Micale L, Mandriani B, Augello B, Pellico MT, Chrast J, et al. TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat. 2014;35:447\u201351. https:\/\/doi.org\/10.1002\/humu.22529","journal-title":"Hum Mutat"},{"key":"4170_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.febslet.2011.02.001","volume":"585","author":"JM Han","year":"2011","unstructured":"Han JM, Sahin M. TSC1\/TSC2 signaling in the CNS. FEBS Lett. 2011;585:973\u201380. https:\/\/doi.org\/10.1016\/j.febslet.2011.02.001","journal-title":"FEBS Lett"},{"key":"4170_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer"},{"key":"4170_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002;4:648\u201357. https:\/\/doi.org\/10.1038\/ncb839","journal-title":"Nat Cell Biol"},{"key":"4170_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ncb840","volume":"4","author":"CJ Potter","year":"2002","unstructured":"Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. 2002;4:658\u201365. https:\/\/doi.org\/10.1038\/ncb840","journal-title":"Nat Cell Biol"},{"key":"4170_CR29","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","volume":"19","author":"G Benvenuto","year":"2000","unstructured":"Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene. 2000;19:6306\u201316. https:\/\/doi.org\/10.1038\/sj.onc.1204009","journal-title":"Oncogene"},{"key":"4170_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","volume":"130","author":"D Lee","year":"2007","unstructured":"Lee D, Kuo H, Chen C, Hsu J, Chou C, Wei Y, et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell. 2007;130:440\u201355. https:\/\/doi.org\/10.1016\/j.cell.2007.05.058","journal-title":"Cell"},{"key":"4170_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/s0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115:577\u201390. https:\/\/doi.org\/10.1016\/s0092-8674(03)00929-2","journal-title":"Cell"},{"key":"4170_CR32","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.2000590","volume":"3","author":"HP Kuo","year":"2010","unstructured":"Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, Lee HJ, et al. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal. 2010;3:ra9. https:\/\/doi.org\/10.1126\/scisignal.2000590","journal-title":"Sci Signal"},{"key":"4170_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274\u201393. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"key":"4170_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023;8:375. https:\/\/doi.org\/10.1038\/s41392-023-01608-z","journal-title":"Signal Transduct Target Ther"},{"key":"4170_CR35","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1101\/gad.351605","volume":"19","author":"I Ruvinsky","year":"2005","unstructured":"Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 2005;19:2199\u2013211. https:\/\/doi.org\/10.1101\/gad.351605","journal-title":"Genes Dev"},{"key":"4170_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"X Ma","year":"2009","unstructured":"Ma X, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307\u201318. https:\/\/doi.org\/10.1038\/nrm2672","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4170_CR37","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","volume":"185","author":"S Battaglioni","year":"2022","unstructured":"Battaglioni S, Benjamin D, W\u00e4lchli M, Maier T, Hall MN. mTOR substrate phosphorylation in growth control. Cell. 2022;185:1814\u201336. https:\/\/doi.org\/10.1016\/j.cell.2022.04.013","journal-title":"Cell"},{"key":"4170_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21:183\u2013203. https:\/\/doi.org\/10.1038\/s41580-019-0199-y","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4170_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0092-8674(01)00332-4","volume":"105","author":"N Tapon","year":"2001","unstructured":"Tapon N, Ito N, Dickson B, Treisman J, Hariharan I. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell. 2001;105:345\u201355. https:\/\/doi.org\/10.1016\/s0092-8674(01)00332-4","journal-title":"Cell"},{"key":"4170_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/bj20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412:179\u201390. https:\/\/doi.org\/10.1042\/bj20080281","journal-title":"Biochem J"},{"key":"4170_CR41","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4161\/auto.25722","volume":"9","author":"P Castets","year":"2013","unstructured":"Castets P, R\u00fcegg MA. MTORC1 determines autophagy through ULK1 regulation in skeletal muscle. Autophagy. 2013;9:1435\u20137. https:\/\/doi.org\/10.4161\/auto.25722","journal-title":"Autophagy"},{"key":"4170_CR42","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18:744\u201357. https:\/\/doi.org\/10.1038\/s41568-018-0074-8","journal-title":"Nat Rev Cancer"},{"key":"4170_CR43","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1073\/pnas.0602282103","volume":"103","author":"Q Yang","year":"2006","unstructured":"Yang Q, Inoki K, Kim E, Guan KL. TSC1\/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc Natl Acad Sci USA. 2006;103:6811\u20136. https:\/\/doi.org\/10.1073\/pnas.0602282103","journal-title":"Proc Natl Acad Sci USA"},{"key":"4170_CR44","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1158\/2159-8290.Cd-15-0460","volume":"5","author":"P Liu","year":"2015","unstructured":"Liu P, Gan W, Chin YR, Ogura K, Guo J, Zhang J, et al. PtdIns(3,4,5)P3-Dependent activation of the mTORC2 kinase complex. Cancer Discov. 2015;5:1194\u2013209. https:\/\/doi.org\/10.1158\/2159-8290.Cd-15-0460","journal-title":"Cancer Discov"},{"key":"4170_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cmet.2013.04.010","volume":"17","author":"SJ Humphrey","year":"2013","unstructured":"Humphrey SJ, Yang G, Yang P, Fazakerley DJ, St\u00f6ckli J, Yang JY, et al. Dynamic adipocyte phosphoproteome reveals that akt directly regulates mTORC2. Cell Metab. 2013;17:1009\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.010","journal-title":"Cell Metab"},{"key":"4170_CR46","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/0008-5472.can-09-0975","volume":"69","author":"J Huang","year":"2009","unstructured":"Huang J, Wu S, Wu CL, Manning BD. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res. 2009;69:6107\u201314. https:\/\/doi.org\/10.1158\/0008-5472.can-09-0975","journal-title":"Cancer Res"},{"key":"4170_CR47","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/jci96342","volume":"128","author":"P Zordan","year":"2018","unstructured":"Zordan P, Cominelli M, Cascino F, Tratta E, Poliani PL, Galli R. Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt. J Clin Invest. 2018;128:1688\u2013706. https:\/\/doi.org\/10.1172\/jci96342","journal-title":"J Clin Invest"},{"key":"4170_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41576-018-0040-z","volume":"19","author":"M Tewary","year":"2018","unstructured":"Tewary M, Shakiba N, Zandstra PW. Stem cell bioengineering: building from stem cell biology. Nat Rev Genet. 2018;19:595\u2013614. https:\/\/doi.org\/10.1038\/s41576-018-0040-z","journal-title":"Nat Rev Genet"},{"key":"4170_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cell.2008.01.038","volume":"132","author":"SJ Morrison","year":"2008","unstructured":"Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008;132:598\u2013611. https:\/\/doi.org\/10.1016\/j.cell.2008.01.038","journal-title":"Cell"},{"key":"4170_CR50","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41580-021-00386-2","volume":"22","author":"JA Saba","year":"2021","unstructured":"Saba JA, Liakath-Ali K, Green R, Watt FM. Translational control of stem cell function. Nat Rev Mol Cell Biol. 2021;22:671\u201390. https:\/\/doi.org\/10.1038\/s41580-021-00386-2","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4170_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","volume":"32","author":"A Kriegstein","year":"2009","unstructured":"Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009;32:149\u201384. https:\/\/doi.org\/10.1146\/annurev.neuro.051508.135600","journal-title":"Annu Rev Neurosci"},{"key":"4170_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrm1739","volume":"6","author":"M G\u00f6tz","year":"2005","unstructured":"G\u00f6tz M, Huttner WB. The cell biology of neurogenesis. Nat Rev Mol Cell Biol. 2005;6:777\u201388. https:\/\/doi.org\/10.1038\/nrm1739","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4170_CR53","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrn.2016.70","volume":"17","author":"B Yao","year":"2016","unstructured":"Yao B, Christian KM, He C, Jin P, Ming GL, Song H. Epigenetic mechanisms in neurogenesis. Nat Rev Neurosci. 2016;17:537\u201349. https:\/\/doi.org\/10.1038\/nrn.2016.70","journal-title":"Nat Rev Neurosci"},{"key":"4170_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1098\/rstb.2006.2013","volume":"363","author":"N Kessaris","year":"2008","unstructured":"Kessaris N, Pringle N, Richardson WD. Specification of CNS glia from neural stem cells in the embryonic neuroepithelium. Philos Trans R Soc Lond B Biol Sci. 2008;363:71\u201385. https:\/\/doi.org\/10.1098\/rstb.2006.2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4170_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/glia.10250","volume":"43","author":"AR Kriegstein","year":"2003","unstructured":"Kriegstein AR, G\u00f6tz M. Radial glia diversity: a matter of cell fate. Glia. 2003;43:37\u201343. https:\/\/doi.org\/10.1002\/glia.10250","journal-title":"Glia"},{"key":"4170_CR56","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","volume":"18","author":"SW Way","year":"2009","unstructured":"Way SW, McKenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet. 2009;18:1252\u201365. https:\/\/doi.org\/10.1093\/hmg\/ddp025","journal-title":"Hum Mol Genet"},{"key":"4170_CR57","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","volume":"9","author":"L Magri","year":"2011","unstructured":"Magri L, Cambiaghi M, Cominelli M, Alfaro-Cervello C, Cursi M, Pala M, et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell. 2011;9:447\u201362. https:\/\/doi.org\/10.1016\/j.stem.2011.09.008","journal-title":"Cell Stem Cell"},{"key":"4170_CR58","doi-asserted-by":"publisher","first-page":"E1070","DOI":"10.1073\/pnas.1106454108","volume":"108","author":"J Goto","year":"2011","unstructured":"Goto J, Talos DM, Klein P, Qin W, Chekaluk YI, Anderl S, et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci USA. 2011;108:E1070\u20139. https:\/\/doi.org\/10.1073\/pnas.1106454108","journal-title":"Proc Natl Acad Sci USA"},{"key":"4170_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fncel.2014.00396","volume":"8","author":"N Urb\u00e1n","year":"2014","unstructured":"Urb\u00e1n N, Guillemot F. Neurogenesis in the embryonic and adult brain: same regulators, different roles. Front Cell Neurosci. 2014;8:396. https:\/\/doi.org\/10.3389\/fncel.2014.00396","journal-title":"Front Cell Neurosci"},{"key":"4170_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1073858420939034","volume":"27","author":"Y Li","year":"2021","unstructured":"Li Y, Guo W. Neural stem cell niche and adult neurogenesis. Neuroscientist. 2021;27:235\u201345. https:\/\/doi.org\/10.1177\/1073858420939034","journal-title":"Neuroscientist"},{"key":"4170_CR61","doi-asserted-by":"publisher","unstructured":"Lim DA, Alvarez-Buylla A. The adult ventricular-subventricular zone (V-SVZ) and olfactory bulb (OB) neurogenesis. Cold Spring Harb Perspect Biol. 2016;8. https:\/\/doi.org\/10.1101\/cshperspect.a018820","DOI":"10.1101\/cshperspect.a018820"},{"key":"4170_CR62","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1101\/gad.16750211","volume":"25","author":"J Zhou","year":"2011","unstructured":"Zhou J, Shrikhande G, Xu J, McKay RM, Burns DK, Johnson JE, et al. Tsc1 mutant neural stem\/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev. 2011;25:1595\u2013600. https:\/\/doi.org\/10.1101\/gad.16750211","journal-title":"Genes Dev"},{"key":"4170_CR63","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1093\/hmg\/ddx214","volume":"26","author":"A Magini","year":"2017","unstructured":"Magini A, Polchi A, Di Meo D, Mariucci G, Sagini K, De Marco F, et al. TFEB activation restores migration ability to Tsc1-deficient adult neural stem\/progenitor cells. Hum Mol Genet. 2017;26:3303\u201312. https:\/\/doi.org\/10.1093\/hmg\/ddx214","journal-title":"Hum Mol Genet"},{"key":"4170_CR64","doi-asserted-by":"publisher","unstructured":"Fu C, Ess KC. Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells. Genesis (New York, N.Y.: 2000) 2013; 51: 284\u201392. https:\/\/doi.org\/10.1002\/dvg.22377","DOI":"10.1002\/dvg.22377"},{"key":"4170_CR65","doi-asserted-by":"publisher","first-page":"eabf5546","DOI":"10.1126\/science.abf5546","volume":"375","author":"OL Eichm\u00fcller","year":"2022","unstructured":"Eichm\u00fcller OL, Corsini NS, V\u00e9rtesy \u00c1, Morassut I, Scholl T, Gruber VE, et al. Amplification of human interneuron progenitors promotes brain tumors and neurological defects. Science. 2022;375:eabf5546. https:\/\/doi.org\/10.1126\/science.abf5546","journal-title":"Science"},{"key":"4170_CR66","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s42255-019-0137-5","volume":"1","author":"C Wang","year":"2019","unstructured":"Wang C, Haas MA, Yang F, Yeo S, Okamoto T, Chen S, et al. Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells. Nat Metab. 2019;1:1127\u201340. https:\/\/doi.org\/10.1038\/s42255-019-0137-5","journal-title":"Nat Metab"},{"key":"4170_CR67","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.stem.2012.05.016","volume":"10","author":"R Lehmann","year":"2012","unstructured":"Lehmann R. Germline stem cells: origin and destiny. Cell Stem Cell. 2012;10:729\u201339. https:\/\/doi.org\/10.1016\/j.stem.2012.05.016","journal-title":"Cell Stem Cell"},{"key":"4170_CR68","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1242\/dev.01026","volume":"131","author":"X Song","year":"2004","unstructured":"Song X, Wong MD, Kawase E, Xi R, Ding BC, McCarthy JJ, et al. Bmp signals from niche cells directly repress transcription of a differentiation-promoting gene, bag of marbles, in germline stem cells in the Drosophila ovary. Development. 2004;131:1353\u201364. https:\/\/doi.org\/10.1242\/dev.01026","journal-title":"Development"},{"key":"4170_CR69","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1242\/dev.051466","volume":"137","author":"P Sun","year":"2010","unstructured":"Sun P, Quan Z, Zhang B, Wu T, Xi R. TSC1\/2 tumour suppressor complex maintains Drosophila germline stem cells by preventing differentiation. Development. 2010;137:2461\u20139. https:\/\/doi.org\/10.1242\/dev.051466","journal-title":"Development"},{"key":"4170_CR70","doi-asserted-by":"publisher","first-page":"467","DOI":"10.15252\/embr.201439379","volume":"16","author":"RM Hobbs","year":"2015","unstructured":"Hobbs RM, La HM, M\u00e4kel\u00e4 JA, Kobayashi T, Noda T, Pandolfi PP. Distinct germline progenitor subsets defined through Tsc2-mTORC1 signaling. EMBO Rep. 2015;16:467\u201380. https:\/\/doi.org\/10.15252\/embr.201439379","journal-title":"EMBO Rep"},{"key":"4170_CR71","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/ar.24486","volume":"303","author":"KM Short","year":"2020","unstructured":"Short KM, Smyth IM. Branching morphogenesis as a driver of renal development. Anat Rec (Hoboken). 2020;303:2578\u201387. https:\/\/doi.org\/10.1002\/ar.24486","journal-title":"Anat Rec (Hoboken)"},{"key":"4170_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41581-022-00620-w","volume":"18","author":"AJ Perl","year":"2022","unstructured":"Perl AJ, Schuh MP, Kopan R. Regulation of nephron progenitor cell lifespan and nephron endowment. Nat Rev Nephrol. 2022;18:683\u201395. https:\/\/doi.org\/10.1038\/s41581-022-00620-w","journal-title":"Nat Rev Nephrol"},{"key":"4170_CR73","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1038\/s41467-021-26626-9","volume":"12","author":"AE Jarmas","year":"2021","unstructured":"Jarmas AE, Brunskill EW, Chaturvedi P, Salomonis N, Kopan R. Progenitor translatome changes coordinated by Tsc1 increase perception of wnt signals to end nephrogenesis. Nat Commun. 2021;12:6332. https:\/\/doi.org\/10.1038\/s41467-021-26626-9","journal-title":"Nat Commun"},{"key":"4170_CR74","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1073\/pnas.1712955115","volume":"115","author":"O Volovelsky","year":"2018","unstructured":"Volovelsky O, Nguyen T, Jarmas AE, Combes AN, Wilson SB, Little MH, et al. Hamartin regulates cessation of mouse nephrogenesis independently of Mtor. Proc Natl Acad Sci USA. 2018;115:5998\u20136003. https:\/\/doi.org\/10.1073\/pnas.1712955115","journal-title":"Proc Natl Acad Sci USA"},{"key":"4170_CR75","doi-asserted-by":"publisher","unstructured":"Nechama M, Makayes Y, Resnick E, Meir K, Volovelsky O. Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease. JCI Insight. 2020;5. https:\/\/doi.org\/10.1172\/jci.insight.136857","DOI":"10.1172\/jci.insight.136857"},{"key":"4170_CR76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16:19\u201334. https:\/\/doi.org\/10.1038\/s41575-018-0081-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4170_CR77","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"126","author":"K Inoki","year":"2006","unstructured":"Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, et al. TSC2 integrates wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;126:955\u201368. https:\/\/doi.org\/10.1016\/j.cell.2006.06.055","journal-title":"Cell"},{"key":"4170_CR78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41467-019-13911-x","volume":"11","author":"D He","year":"2020","unstructured":"He D, Wu H, Xiang J, Ruan X, Peng P, Ruan Y, et al. Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nat Commun. 2020;11:37. https:\/\/doi.org\/10.1038\/s41467-019-13911-x","journal-title":"Nat Commun"},{"key":"4170_CR79","doi-asserted-by":"publisher","first-page":"E10362","DOI":"10.1073\/pnas.1808575115","volume":"115","author":"H Zeng","year":"2018","unstructured":"Zeng H, Lu B, Zamponi R, Yang Z, Wetzel K, Loureiro J, et al. mTORC1 signaling suppresses Wnt\/\u03b2-catenin signaling through DVL-dependent regulation of wnt receptor FZD level. Proc Natl Acad Sci USA. 2018;115:E10362\u20139. https:\/\/doi.org\/10.1073\/pnas.1808575115","journal-title":"Proc Natl Acad Sci USA"},{"key":"4170_CR80","doi-asserted-by":"publisher","first-page":"e1003045","DOI":"10.1371\/journal.pgen.1003045","volume":"8","author":"S Kapuria","year":"2012","unstructured":"Kapuria S, Karpac J, Biteau B, Hwangbo D, Jasper H. Notch-mediated suppression of TSC2 expression regulates cell differentiation in the Drosophila intestinal stem cell lineage. PLoS Genet. 2012;8:e1003045. https:\/\/doi.org\/10.1371\/journal.pgen.1003045","journal-title":"PLoS Genet"},{"key":"4170_CR81","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","volume":"132","author":"SH Orkin","year":"2008","unstructured":"Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132:631\u201344. https:\/\/doi.org\/10.1016\/j.cell.2008.01.025","journal-title":"Cell"},{"key":"4170_CR82","doi-asserted-by":"publisher","first-page":"19384","DOI":"10.1073\/pnas.0810584105","volume":"105","author":"B Gan","year":"2008","unstructured":"Gan B, Sahin E, Jiang S, Sanchez-Aguilera A, Scott KL, Chin L, et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci USA. 2008;105:19384\u20139. https:\/\/doi.org\/10.1073\/pnas.0810584105","journal-title":"Proc Natl Acad Sci USA"},{"key":"4170_CR83","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1084\/jem.20081297","volume":"205","author":"C Chen","year":"2008","unstructured":"Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med. 2008;205:2397\u2013408. https:\/\/doi.org\/10.1084\/jem.20081297","journal-title":"J Exp Med"},{"key":"4170_CR84","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1242\/dev.074203","volume":"139","author":"M Dragojlovic-Munther","year":"2012","unstructured":"Dragojlovic-Munther M, Martinez-Agosto JA. Multifaceted roles of PTEN and TSC orchestrate growth and differentiation of Drosophila blood progenitors. Development. 2012;139:3752\u201363. https:\/\/doi.org\/10.1242\/dev.074203","journal-title":"Development"},{"key":"4170_CR85","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137. https:\/\/doi.org\/10.1126\/science.284.5411.143","journal-title":"Science"},{"key":"4170_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12015-021-10231-w","volume":"18","author":"U Galderisi","year":"2022","unstructured":"Galderisi U, Peluso G, Di Bernardo G. Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years? Stem Cell Rev Rep. 2022;18:23\u201336. https:\/\/doi.org\/10.1007\/s12015-021-10231-w","journal-title":"Stem Cell Rev Rep"},{"key":"4170_CR87","doi-asserted-by":"publisher","unstructured":"Kulus M, Sibiak R, Stefa\u0144ska K, Zdun M, Wieczorkiewicz M, Piotrowska-Kempisty H, et al. Mesenchymal Stem\/Stromal cells derived from Human and Animal Perinatal Tissues-Origins, characteristics, Signaling pathways, and clinical trials. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10123278","DOI":"10.3390\/cells10123278"},{"key":"4170_CR88","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641\u201350. https:\/\/doi.org\/10.1002\/jor.1100090504","journal-title":"J Orthop Res"},{"key":"4170_CR89","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/sctm.17-0129","volume":"6","author":"R Samsonraj","year":"2017","unstructured":"Samsonraj R, Raghunath M, Nurcombe V, Hui J, van Wijnen A, Cool S. Concise Review: multifaceted characterization of human mesenchymal stem cells for Use in Regenerative Medicine. Stem Cells Translational Med. 2017;6:2173\u201385. https:\/\/doi.org\/10.1002\/sctm.17-0129","journal-title":"Stem Cells Translational Med"},{"key":"4170_CR90","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.stemcr.2017.04.005","volume":"8","author":"H Wu","year":"2017","unstructured":"Wu H, Wu Z, Li P, Cong Q, Chen R, Xu W, et al. Bone size and quality regulation: concerted actions of mTOR in mesenchymal stromal cells and osteoclasts. Stem cell Rep. 2017;8:1600\u201316. https:\/\/doi.org\/10.1016\/j.stemcr.2017.04.005","journal-title":"Stem cell Rep"},{"key":"4170_CR91","doi-asserted-by":"publisher","unstructured":"Guijarro MV, Danielson LS, Ca\u00f1amero M, Nawab A, Abrahan C, Hernando E, et al. Tsc1 regulates the proliferation capacity of bone-marrow derived mesenchymal stem cells. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9092072","DOI":"10.3390\/cells9092072"},{"key":"4170_CR92","doi-asserted-by":"publisher","first-page":"4572687","DOI":"10.1155\/2020\/4572687","volume":"2020","author":"C Yang","year":"2020","unstructured":"Yang C, Liao J, Lai P, Huang H, Fan S, Chen Y, et al., et al. Mesenchymal stem cell-specific and preosteoblast-specific ablation of TSC1 in mice lead to severe and slight spinal dysplasia, respectively. Biomed Res Int. 2020;2020:4572687. https:\/\/doi.org\/10.1155\/2020\/4572687","journal-title":"Biomed Res Int"},{"key":"4170_CR93","doi-asserted-by":"publisher","first-page":"39457","DOI":"10.18632\/oncotarget.6277","volume":"6","author":"S Capasso","year":"2015","unstructured":"Capasso S, Alessio N, Squillaro T, Di Bernardo G, Melone MA, Cipollaro M, et al. Changes in autophagy, proteasome activity and metabolism to determine a specific signature for acute and chronic senescent mesenchymal stromal cells. Oncotarget. 2015;6:39457\u201368. https:\/\/doi.org\/10.18632\/oncotarget.6277","journal-title":"Oncotarget"},{"key":"4170_CR94","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/jci17222","volume":"112","author":"H Zhang","year":"2003","unstructured":"Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, et al. Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest. 2003;112:1223\u201333. https:\/\/doi.org\/10.1172\/jci17222","journal-title":"J Clin Invest"},{"key":"4170_CR95","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet. 1999;64:1305\u201315. https:\/\/doi.org\/10.1086\/302381","journal-title":"Am J Hum Genet"},{"key":"4170_CR96","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13229-020-0320-2","volume":"11","author":"W Afshar Saber","year":"2020","unstructured":"Afshar Saber W, Sahin M. Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex. Mol Autism. 2020;11:16. https:\/\/doi.org\/10.1186\/s13229-020-0320-2","journal-title":"Mol Autism"},{"key":"4170_CR97","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41591-018-0139-y","volume":"24","author":"JD Blair","year":"2018","unstructured":"Blair JD, Hockemeyer D, Bateup HS. Genetically engineered human cortical spheroid models of tuberous sclerosis. Nat Med. 2018;24:1568\u201378. https:\/\/doi.org\/10.1038\/s41591-018-0139-y","journal-title":"Nat Med"},{"key":"4170_CR98","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277:805\u20138. https:\/\/doi.org\/10.1126\/science.277.5327.805","journal-title":"Science"},{"key":"4170_CR99","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00431-001-0903-7","volume":"161","author":"N Langkau","year":"2002","unstructured":"Langkau N, Martin N, Brandt R, Z\u00fcgge K, Quast S, Wiegele G, et al. TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1\/ TSC2 frequency ratios. Eur J Pediatr. 2002;161:393\u2013402. https:\/\/doi.org\/10.1007\/s00431-001-0903-7","journal-title":"Eur J Pediatr"},{"key":"4170_CR100","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","volume":"7","author":"M van Slegtenhorst","year":"1998","unstructured":"van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet. 1998;7:1053\u20137. https:\/\/doi.org\/10.1093\/hmg\/7.6.1053","journal-title":"Hum Mol Genet"},{"key":"4170_CR101","doi-asserted-by":"publisher","first-page":"29301","DOI":"10.1074\/jbc.272.46.29301","volume":"272","author":"T Soucek","year":"1997","unstructured":"Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschl\u00e4ger M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem. 1997;272:29301\u20138. https:\/\/doi.org\/10.1074\/jbc.272.46.29301","journal-title":"J Biol Chem"},{"key":"4170_CR102","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.stemcr.2017.02.020","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Cao J, Chen M, Li J, Sun Y, Zhang Y, et al. Abnormal neural progenitor cells differentiated from Induced Pluripotent stem cells partially mimicked development of TSC2 neurological abnormalities. Stem cell Rep. 2017;8:883\u201393. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.020","journal-title":"Stem cell Rep"},{"key":"4170_CR103","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/hmg\/ddr511","volume":"21","author":"D Feliciano","year":"2012","unstructured":"Feliciano D, Quon J, Su T, Taylor M, Bordey A. Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion. Hum Mol Genet. 2012;21:799\u2013810. https:\/\/doi.org\/10.1093\/hmg\/ddr511","journal-title":"Hum Mol Genet"},{"key":"4170_CR104","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1242\/jcs.125294","volume":"126","author":"Z Quan","year":"2013","unstructured":"Quan Z, Sun P, Lin G, Xi R. TSC1\/2 regulates intestinal stem cell maintenance and lineage differentiation through Rheb-TORC1-S6K but independently of nutritional status or notch regulation. J Cell Sci. 2013;126:3884\u201392. https:\/\/doi.org\/10.1242\/jcs.125294","journal-title":"J Cell Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04170-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04170-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04170-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T03:11:28Z","timestamp":1738638688000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04170-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04170-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that the research was conducted in the absence of any financial or commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}